Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ABP-450 for safety and efficacy in cervical dystonia has been completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dystonia

Drugs mentioned

• ABP-450

Snippet

Sponsor: AEON Biopharma, Inc. | Conditions: Cervical Dystonia | Phase 2 | Status: COMPLETED | Results posted: 2024-02-14